Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Antibody Response
100%
Severe Acute Respiratory Syndrome Coronavirus 2
95%
Infection
70%
COVID-19
68%
Binding Antibody
66%
Severe Acute Respiratory Syndrome
47%
Bacterial Cell
47%
Influenza A Virus (H1N1)
47%
Capsid
47%
Immunogenicity
47%
Cancer Cell
47%
Mumps virus
47%
Colon
47%
Neutralizing Antibody
38%
Immune Response
32%
Antibody Blood Level
31%
Antigenic Variation
31%
Cell Viability
31%
Influenza
23%
Cross-Reactivity
23%
DNA Immunization
23%
Syrian hamster
23%
Biological Activity
15%
Bacterial Growth
15%
Spike
15%
Transmission Electron Microscopy
15%
Scanning Electron Microscopy
15%
Infrared Radiation
15%
Seropositivity
15%
UV-Visible Spectroscopy
15%
MMR Vaccine
15%
Codon
15%
Humoral Antibody
13%
Blood Level
9%
Virus Spike
9%
Virus
9%
Influenza Vaccine
9%
Adoptive Immunity
9%
Interferon
9%
Emerging Viruses
9%
Immunoglobulin G2
9%
Plasmid
9%
Prevalence
7%
Comorbidity
7%
Mortality Rate
7%
Dynamics
7%
Titer
7%
Antibody Titer
7%
Amino Acid Sequence
7%
Virus Infectivity
6%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
98%
Coronavirinae
61%
Mumps virus
47%
Rubella Virus
47%
Immunogenicity
47%
Coronaviridae
47%
Amino Acid
47%
Influenza A Virus (H1N1)
47%
DNA Immunization
47%
Influenza Vaccine
47%
Zika Virus Vaccine
47%
Epitope
41%
Neutralizing Antibody
40%
Diseases
36%
Seasonal Influenza
31%
Middle East Respiratory Syndrome Coronavirus
27%
Mesoporous Silica Nanoparticle
23%
Nucleic Acid
23%
Syrian hamster
23%
Measles virus
23%
Zika virus
20%
Pandemic
19%
Live Attenuated Influenza Vaccine
15%
Bacteriophage
15%
Humoral Antibody
11%
COVID-19 Vaccine
11%
Thermostability
11%
Immunoglobulin G2
11%
Protein Vaccine
11%
Infection
9%
Interferon
9%
Reinfection
9%
Leporidae
7%
Messenger RNA
5%
mRNA Vaccine
5%
Nucleic Acid-Based Vaccine
5%
Syndrome
5%
Neurological Complication
5%
Glycoprotein
5%
Biochemistry, Genetics and Molecular Biology
Coronavirinae
47%
Capsid
47%
Nucleic Acid
47%
Mumps virus
47%
Antibody Response
41%
Antigenic Variation
31%
SARS Coronavirus
29%
Neutralizing Antibody
28%
Zika virus
23%
Measles virus
23%
Cell Viability
23%
Rubella Virus
23%
Observational Study
23%
Bacterial Growth
23%
Colon
23%
B Cell
21%
Middle East Respiratory Syndrome Coronavirus
17%
Genetics
15%
Herd Immunity
15%
Titer
15%
Sequence Alignment
14%
Infectious Agent
13%
Scanning Electron Microscopy
11%
Transmission Electron Microscopy
11%
Infrared Radiation
11%
Messenger RNA
11%
Anticancer
11%
HEK 293 Cells
11%
Biological Activity
11%
Mortality Rate
9%
Virus Spike
9%
Interferon
9%
Cellular Immunity
9%
S1 Domain
7%
Spike
7%
T Cell
7%
Gene Product
7%
Immune Response
7%
Peptide Sequence
7%
Cross Reaction
6%
Glycosylation
6%
Codon
5%